PC Robinson, DFL Liew, HL Tanner… - Proceedings of the …, 2022 - National Acad Sciences
… Antivirals justifiably remain the focus for treatment in early COVID-19. Two main approaches exist: direct acting antivirals (DAAs) that target viral proteins, and less developed host-…
… High doses of ascorbic acid (vitamin C) are suggested for the prevention of the COVID-19 disease [… The use of convalescent plasma for the treatment of COVID-19 has been suggested. …
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
… coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus … identify effective drugs for prevention and treatment. Given the rapid pace of …
PK Samudrala, P Kumar, K Choudhary… - European journal of …, 2020 - Elsevier
… In the treatment group, given 400 mg of the drug daily for 5 days and in control group … conventional treatment only. This report showed that 86% and 93% of the patients had COVID19 …
… No current targeted treatment is yet available for COVID-19, an unknown disease up to 2 … or reallocate other treatments for these patients. Since the beginning of the COVID-19 outbreak, …
KS Saini, B de Las Heras, J de Castro… - The Lancet …, 2020 - thelancet.com
… shorten the treatment duration. Patients with cancer who develop COVID-19 should be treated in the respiratory or intensive care units rather than in the oncology or radiotherapy units. …
… associated with coronavirus disease 2019 (COVID-19) … -antibody treatment has been widely used to treat COVID-19, … Thus, the therapeutic use of COVID-19 convalescent plasma …
… treatment of COVID-19. Remdesivir was touted as a potential candidate drug for the treatment of COVID-19. … a ‘molecule of hope’ for the treatment of COVID-19 [6]. On the 22nd October …
… and COVID-19 and to prevent the transmission of coronavirus. The COVID-19 pandemic … health policies globally, as it requires novel treatment and prevention strategies to adapt for the …